Business Description
Qingdao Baheal Medical Inc
ISIN : CNE100004LR8
Share Class Description:
SZSE:301015: Class ACompare
Compare
Traded in other countries / regions
301015.China IPO Date
2021-06-30Description
Qingdao Baheal Medical Inc is engaged in providing comprehensive marketing services for pharmaceutical product manufacturers.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.96 | |||||
| Equity-to-Asset | 0.5 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 1.61 | |||||
| Interest Coverage | 15.93 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.69 | |||||
| Beneish M-Score | -2.23 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.3 | |||||
| 3-Year EBITDA Growth Rate | 24.4 | |||||
| 3-Year EPS without NRI Growth Rate | 25.1 | |||||
| 3-Year Book Growth Rate | 17.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.51 | |||||
| 9-Day RSI | 51.59 | |||||
| 14-Day RSI | 50.73 | |||||
| 6-1 Month Momentum % | -12.28 | |||||
| 12-1 Month Momentum % | 27 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | |||||
| Quick Ratio | 2.07 | |||||
| Cash Ratio | 0.77 | |||||
| Days Inventory | 46.61 | |||||
| Days Sales Outstanding | 96.94 | |||||
| Days Payable | 64.92 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.31 | |||||
| Dividend Payout Ratio | 0.56 | |||||
| Forward Dividend Yield % | 2.31 | |||||
| 5-Year Yield-on-Cost % | 2.24 | |||||
| 3-Year Average Share Buyback Ratio | -3.6 | |||||
| Shareholder Yield % | 1.02 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.16 | |||||
| Operating Margin % | 13.17 | |||||
| Net Margin % | 9.28 | |||||
| FCF Margin % | 6.06 | |||||
| ROE % | 27.32 | |||||
| ROA % | 13.06 | |||||
| ROIC % | 25.02 | |||||
| ROC (Joel Greenblatt) % | 49.51 | |||||
| ROCE % | 30.6 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 25.45 | |||||
| PE Ratio without NRI | 24.39 | |||||
| Price-to-Owner-Earnings | 27.85 | |||||
| PEG Ratio | 1.24 | |||||
| PS Ratio | 2.38 | |||||
| PB Ratio | 6.12 | |||||
| Price-to-Tangible-Book | 6.34 | |||||
| Price-to-Free-Cash-Flow | 38.49 | |||||
| Price-to-Operating-Cash-Flow | 29.84 | |||||
| EV-to-EBIT | 17.96 | |||||
| EV-to-EBITDA | 17.96 | |||||
| EV-to-Revenue | 2.38 | |||||
| EV-to-FCF | 38.52 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.41 | |||||
| Price-to-Graham-Number | 2.62 | |||||
| Price-to-Net-Current-Asset-Value | 8.77 | |||||
| Earnings Yield (Greenblatt) % | 5.57 | |||||
| FCF Yield % | 2.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Qingdao Baheal Medical Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 7,538.639 | ||
| EPS (TTM) (Â¥) | 1.296 | ||
| Beta | 0 | ||
| Volatility % | 54.03 | ||
| 14-Day RSI | 50.73 | ||
| 14-Day ATR (Â¥) | 1.371754 | ||
| 20-Day SMA (Â¥) | 32.404 | ||
| 12-1 Month Momentum % | 27 | ||
| 52-Week Range (Â¥) | 21.4 - 43.5 | ||
| Shares Outstanding (Mil) | 525.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Qingdao Baheal Medical Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Qingdao Baheal Medical Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Qingdao Baheal Medical Inc Frequently Asked Questions
What is Qingdao Baheal Medical Inc(SZSE:301015)'s stock price today?
The current price of SZSE:301015 is ¥32.98. The 52 week high of SZSE:301015 is ¥43.50 and 52 week low is ¥21.40.
When is next earnings date of Qingdao Baheal Medical Inc(SZSE:301015)?
The next earnings date of Qingdao Baheal Medical Inc(SZSE:301015) is .
Does Qingdao Baheal Medical Inc(SZSE:301015) pay dividends? If so, how much?
The Dividend Yield %  of Qingdao Baheal Medical Inc(SZSE:301015) is 2.31% (As of Today), Highest Dividend Payout Ratio of Qingdao Baheal Medical Inc(SZSE:301015) was 0.7. The lowest was 0.56. And the median was 0.67. The  Forward Dividend Yield % of Qingdao Baheal Medical Inc(SZSE:301015) is 2.31%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers